Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Journal of Oncology
|
October 23, 2019
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma
Andrew D Ludwig, Kevin P Labadie, Y David Seo, et al.
Plos One
|
November 9, 2013
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling
Holly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, et al.
Scientific Reports
|
June 26, 2021
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
En-Chi Hsu, Michelle Shen, Merve Aslan, et al.
Molecular Cancer Therapeutics
|
February 15, 2020
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models
Ulrike Weyer-Czernilofsky, Marco H Hofmann, Katrin Friedbichler, et al.
The Journal of Clinical Investigation
|
July 21, 2010
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun, Cynthia C T Sprenger, Robert L Vessella, et al.
Journal of Cellular Physiology
|
January 17, 2016
Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming
Gisely T Borges, Eneida F Vêncio, Sue-Ing Quek, et al.
Endocrinology
|
May 15, 2013
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models
Khalid Z Masoodi, Raquel Ramos Garcia, Laura E Pascal, et al.
British Journal of Cancer
|
October 5, 2023
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype
Michelle Shen, Shiqin Liu, Angus Toland, et al.
Scientific Reports
|
February 26, 2021
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture
Elise Y Cai, Jose Garcia, Yuzhen Liu, et al.
The Prostate
|
February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics
Holly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Journal of Oncology
|
October 23, 2019
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma
Andrew D Ludwig, Kevin P Labadie, Y David Seo, et al.
Plos One
|
November 9, 2013
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling
Holly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, et al.
Scientific Reports
|
June 26, 2021
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
En-Chi Hsu, Michelle Shen, Merve Aslan, et al.
Molecular Cancer Therapeutics
|
February 15, 2020
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models
Ulrike Weyer-Czernilofsky, Marco H Hofmann, Katrin Friedbichler, et al.
The Journal of Clinical Investigation
|
July 21, 2010
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun, Cynthia C T Sprenger, Robert L Vessella, et al.
Journal of Cellular Physiology
|
January 17, 2016
Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming
Gisely T Borges, Eneida F Vêncio, Sue-Ing Quek, et al.
Endocrinology
|
May 15, 2013
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models
Khalid Z Masoodi, Raquel Ramos Garcia, Laura E Pascal, et al.
British Journal of Cancer
|
October 5, 2023
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype
Michelle Shen, Shiqin Liu, Angus Toland, et al.
Scientific Reports
|
February 26, 2021
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture
Elise Y Cai, Jose Garcia, Yuzhen Liu, et al.
The Prostate
|
February 4, 2017
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics
Holly M Nguyen, Robert L Vessella, Colm Morrissey, et al.
Page
of 5